ArticleScientific reports2022

Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy.

Naoki Kawagishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.